US57777K1060
US57777K1060
MaxCyte, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 33.026.000 | 38.627.000 | 14.5% |
| Cost of Revenue | 6.222.000 | 7.100.000 | 12.4% |
| Gross Profit | 26.804.000 | 31.527.000 | 15.0% |
| 72.089.000 | 82.724.000 | 12.9% | |
| Operating Income | -45.285.000 | -51.197.000 | 11.5% |
| Pretax Income | -44.630.000 | -41.055.000 | 8.7% |
| Net Income Common Stockholders | -44.630.000 | -41.055.000 | 8.7% |
| -- | -- | -- | |
| -- | -- | -- |